脑缺血的神经保护治疗研究现状

Research Status of Neuroprotective therapy for Cerebral Ischemia

目前，在时间窗内进行溶栓治疗是FDA推荐的唯一有效的脑缺血急性期治疗方案，但溶栓时间窗限制了其临床应用，而神经保护则具有更为广泛的适应证，成为脑缺血治疗的研究热点之一。文章综述了目前国内外尚处于实验阶段和已应用于临床的神经保护治疗方法。

Although thrombolytic therapy is the only method recommended by the Food and Drug Administration （FDA） for acute ischemic stroke, the time window limits its application. Thus, neuroprotective research, which has a wider application become the focus. This article summarizes the neruoprotective methods in animal researches and clinical trials.